Sediba Hope Medical Centre

17/11/2025

We're joining the global effort for Hepatitis Testing Week to raise awareness and encourage vital screening. Hepatitis C is often called a "silent epidemic" because many people don't know they have it until symptoms appear much later. But the good news is, Hepatitis C is curable and Hepatitis B is vaccine preventable. We especially want to reach out to members of our community who are most affected or at higher risk for Hepatitis C. This includes people who have ever injected drugs and their injecting or intimate contacts.

Visit Sediba Hope Medical Centre this week for your Hepatitis B & C tests! Know your status, take control of your health.

31/10/2025

We believe in empowering you with the tools to take charge of your health. When it comes to substance use, understanding your own risk is the first crucial step towards well-being. That's why we're encouraging everyone to try the Alcohol, Smoking and Substance Involvement Screening Test free, online tool! It's a quick, confidential, and easy way to assess your own risk and get personalized feedback. Take a few minutes today to check in with yourself.

Click here to take the ASSIST test: https://assistscreening.uct.ac.za/self-screen

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) is a comprehensive risk assessment tool. It makes use of risk categories determined by screening scores to help determine the ideal intervention strategy. The ASSIST asks about recent substance use over the past 3 months and also...

30/10/2025

Viral hepatitis is the leading cause of liver cancer.

As we wrap up and approach , let’s keep raising awareness about this silent killer. Protect your health — get tested for hepatitis! 💪

Take action and show your support by adding your organisation to our map: heptestweek.org

30/10/2025

Our team proudly attending the South African Community Epidemiological Network on Drug Use meeting today at the South African Medical Research Council Pretoria. We're especially excited that our Evaluation of NACOSA Opioid Substitution Therapy Programme & its linkage to other treatment accessibility & uptake by People Who Use Drugs will be shared with service providers from various sectors.

Learn more about SACENDU's vital work: https://www.samrc.ac.za/intramural-research-units/MASTRU-sacendu

SACENDU Privacy Statement  “The South African Community Epidemiology Network on Drug Use (SACENDU), a project of the Mental Health, Alcohol, Substance Use and To***co Research Unit (MAST-RU), upholds the right to privacy, confidentiality and protection of personal information as enshrined in the ...

28/10/2025

We are live at Emperors Palace for the Mental Health Conference 2025! We're excited to be part of this crucial conversation around mental well-being and dedicated to supporting our fellow delegates. Visit us at our stand! We're offering FREE, confidential mental health screens to all delegates. Take a moment for your well-being – it's quick, easy, and a great way to check in with yourself amidst the busy conference schedule. Come say hello, learn more about our services, and how we prioritize your mental health. We look forward to connecting with you!

27/10/2025

SURVEY OPPORTUNITY

We invite your participation in this important survey, developed in collaboration between the Coalition for Global Hepatitis Elimination (CGHE) and the World Health Organization (WHO).

Two short, voluntary surveys (~ 10 minutes each) are open to gather perspectives from:

1. Perspectives among persons who may benefit from testing for HIV, viral hepatitis and STIs:
This survey seeks to understand the values and preferences of people who may benefit from testing, including those living with HIV, or with prior testing/treatment experience for viral hepatitis or other STIs. Your insights will help determine which testing options are most acceptable and useful for people in need of testing and care: https://buff.ly/Sc2k5V7

2. Healthcare providers:
This survey is designed for providers, including physicians, nurses, midwives, pharmacists, community health workers, peer-workers, and laboratory staff. It aims to assess provider perspectives on the acceptability, feasibility, and potential public health impact of multiplex tests: https://buff.ly/McAjBEC

The information collected will directly inform the development of WHO guidelines on multiplex testing. All responses are confidential, and no identifying information will be collected.

27/10/2025

We are incredibly excited about SAHPRA's registration of this long-acting prevention for HIV! This is a monumental step forward in our fight against HIV. This long-acting injectable PrEP offers a new, convenient, and highly effective option, which we believe will be particularly impactful for people disproportionately affected by HIV or at high risk. We look forward to updates on the commencement of roll-out.

Read the full announcement from SAHPRA here: https://www.sahpra.org.za/news-and-updates/sahpra-registers-lenacapavir/

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN), that could bring an end to Aids if enough people take it.

17/10/2025

Honored that our decentralized integrated model has been labeled as one of the 'most exciting innovations in Hepatitis C care' on the closing day of INHSU2025!

16/10/2025

Sediba Hope Medical Centre is presenting on: THE EFFECT OF OPIOID SUBSTITUTION THERAPY ON HEALTH OUTCOMES IN PEOPLE WHO USE DRUGS IN SOUTH AFRICA at INHSU2025. This research provides crucial insights for advancing public health strategies and improving patient care for people who use drugs nationally.

🗓️16 October 2025
⏰14:55 – 15:00 SAST
📍 Hall C, Century City Conference Centre, Cape Town

Let's strengthen healthcare access together!

15/10/2025

We are grateful for the opportunity to share our experience of providing integrated hepatitis c care to people who use drugs with clinicians.

15/10/2025

Learn about the effectiveness of community-based care at INHSU 2025. We will present a poster on the quality of the NACOSA Opioid Substitution Therapy Programme, demonstrating how it enabless to positive health outcomes and offering a road map to long-term sustainability.

🗓️15 Oct (15:15 SAST) & 17 Oct (11:00 SAST)

📍Hall D, Century City Conference Centre, Cape Town

15/10/2025

Sediba Hope Medical Centre is sharing critical findings on viral hepatitis and HIV co-infection rates in Tshwane, South Africa. Our findings underscore the persistent, escalating burden of HCV and HIV in people who inject drugs over the past decade, and highlights the crucial need for continued surveillance, access to treatment, and targeted prevention efforts.

🗓️15 October 2025 | 15:15 – 16:00 SAST
17 October 2025 | 11:00 – 11:45 SAST

📍Hall D, Century City Conference Centre, Cape Town